API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 2 sources · 27 days · First seen · Last updated

European oncology center accreditations

Overview

European cancer institutions have received high-level recognitions from major medical organizations.

In late September 2026, the Organisation of European Cancer Institutes (OECI) granted the ‘Comprehensive Cancer Centre with Research Excellence’ designation to INOC in Italy and Maastricht UMC+ in the Netherlands. This classification is reserved for institutions that integrate clinical care, scientific research, and innovation according to European quality standards.

Following this, the Portuguese Institute of Oncology of Coimbra Francisco Gentil (IPO de Coimbra) received recognition from the European Society for Medical Oncology (ESMO). Designated as an ‘ESMO Designated Centre of Integrated Oncology and Palliative Care’ for the 2027–2029 period, the institution was recognized for its person-centered approach that combines oncological treatments with palliative care.

Entities

Organisation of European Cancer Institutes · INOC · OncoZON · Instituto Português de Oncologia de Coimbra Francisco Gentil · European Society for Medical Oncology

Timeline

  1. [HEALTH] 2 sources
    IPO de Coimbra receives European oncology distinction

    The Portuguese Institute of Oncology of Coimbra has been named an ESMO Designated Centre of Integrated Oncology and Palliative Care for 2027-2029.

  2. [HEALTH] 2 sources
    European cancer centers INOC and Maastricht UMC+ receive top OECI designation

    INOC and Maastricht UMC+ have received the highest OECI designation, ‘Comprehensive Cancer Centre with Research Excellence’, recognizing their integration of clinical care and scientific research.

Sources

metropoles.com · miraonline.pt